Highlands Oncology is a clinical research site located in Springdale, Arkansas, United States 72762.
Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.
Highlands Oncology has participated in 10 clinical trials with 2 currently active.
Therapeutic areas: HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer, Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors, Solid Tumor.
Sponsors: Pfizer, Tempus AI, Navire Pharma Inc., a BridgeBio company.
Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Highlands Oncology has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Highlands Oncology has 10 clinical trials on record, with 2 currently active. Their work covers HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer, Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors, Solid Tumor.
Highlands Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.